EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases

Aparna Bhanushali iD, Sachin Atre iD, Preethi Nair, Geethanjali Anilkumar Thandaseery, Sanchi Shah, Sanjana Kuruwa, Amrutraj Zade, Chaitali Nikam, Mangala Gomare, Anirvan Chatterjee iD

Microbiology Spectrum · 02.05.2024 · 12 (5)

DOI: 10.1128/spectrum.02770-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.05.2024. Verfasst von Aparna Bhanushali und 9 weiteren Autor:innen. Beteiligte Einrichtung: HaystackAnalytics Pvt. Ltd., IIT Bombay, Mumbai, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Whole Genome Sequencing, Antitubercular Agents, Extensively Drug-Resistant Tuberculosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment decisions for tuberculosis (TB) in the absence of full drug-susceptibility data can result in amplifying resistance and may compromise treatment outcomes. Genomics of Mycobacterium tuberculosis ( M.tb ) from clinical samples enables detection of drug resistance to multiple drugs. We performed whole-genome sequencing (WGS) for 600 clinical samples from patients with tuberculosis to identify the drug-resistance profile and mutation spectrum. We documented the reasons reported by clinicians for referral. WGS identified a high proportion (51%) of pre-extensively drug-resistant (pre-XDR) cases followed by multidrug-resistant tuberculosis (MDR-TB) (15.5%). This correlates with the primary reason for referral, as non-response to the first-line treatment (67%) and treatment failure or rifampicin resistance (14%). Multivariate analysis indicated that all young age groups ( P < 0.05), male gender ( P < 0.05), and Beijing strain ( P < 0.01) were significant independent predictors of MDR-TB or MDR-TB+ [pre-extensively drug-resistant tuberculosis (XDR-TB) and XDR-TB]. Ser315Thr (72.5%) in the inhA gene and Ser450Leu in the rpoB gene (65.5%) were the most prevalent mutations, as were resistance-conferring mutations to pyrazinamide (41%) and streptomycin (61.33%). Mutations outside the rifampicin resistance-determining region (RRDR), Ile491Phe and Val170Phe, were seen in 1.3% of cases; disputed mutations in rpoB (Asp435Tyr, His445Asn, His445Leu, and Leu430Pro) were seen in 6% of cases, and mutations to newer drugs such as bedaquiline and linezolid in 1.0% and 7.5% of cases, respectively. This study on clinical samples highlights that there is a high proportion of pre-XDR cases and emerging resistance to newer drugs; ongoing transmission of these strains can cause serious threat to public health; and whole-genome sequencing can effectively identify and support precision medicine for TB. IMPORTANCE The current study is based on real-world data on the TB drug-resistance profile by whole-genome sequencing of 600 clinical samples from patients with TB in India. This study indicates the clinicians’ reasons for sending samples for WGS, which is for difficult-to-treat cases and/or relapse and treatment failure. The study reports a significant proportion of cases with pre-XDR-TB strains that warrant policy makers’ attention. It reflects the current iterative nature of the diagnostic tests under programmatic conditions that leads to delays in appropriate diagnosis and empirical treatment. India had an estimated burden of 2.95 million TB cases in 2020 and 135,000 multidrug-resistant cases. However, WGS profiles of M.tb from India remains disproportionately poorly represented. This study adds a significant body of data on the mutation profiles seen in M.tb isolated from patients with TB in India, mutations outside the RRDR, disputed mutations, and resistance-conferring mutations to newer drugs such as bedaquiline and linezolid.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisWhole Genome SequencingAntitubercular AgentsExtensively Drug-Resistant TuberculosisMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialMutationTuberculosis, Multidrug-ResistantOxidoreductasesDNA-Directed RNA PolymerasesHumansIndiaMaleFemaleAdultMiddle AgedBacterial ProteinsYoung AdultAdolescentAgedRifampin

Stichwörter der Autor:innen

IndiaMycobacterium tuberculosisdrug-resistance mechanismsdrug-sensitivity testingmolecular biologymolecular diagnosticsmultidrug resistantphylogenywhole-genome sequencing

Substanzen

Antitubercular AgentsBacterial ProteinsrpoB protein, Mycobacterium tuberculosisRifampinInhA protein, MycobacteriumOxidoreductasesDNA-Directed RNA Polymerases

Autor:innen und Institutionen

  • HaystackAnalytics Pvt. Ltd., IIT Bombay, Mumbai, India.
  • Dr. D.Y. Patil Medical College Hospital and Research Centre, Pune, India.
  • Thyrocare Technologies Ltd., Navi Mumbai, India.
  • BrihanMumbai Municipal Corporation, Mumbai, India.

ORCID-Profile: Aparna Bhanushali, Sachin Atre, Anirvan Chatterjee

Zitieren

APA

Bhanushali, A., Atre, S., Nair, P., Thandaseery, G. A., Shah, S., Kuruwa, S., Zade, A., Nikam, C., Gomare, M., & Chatterjee, A. (2024). Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases. Microbiology Spectrum, 12(5). https://doi.org/10.1128/spectrum.02770-23

Vancouver

Bhanushali A, Atre S, Nair P, Thandaseery GA, Shah S, Kuruwa S, et al. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases. Microbiology Spectrum. 2024;12(5). doi:10.1128/spectrum.02770-23

BibTeX
@article{Bhanushali2024,
  author = {Bhanushali, Aparna and Atre, Sachin and Nair, Preethi and Thandaseery, Geethanjali Anilkumar and Shah, Sanchi and Kuruwa, Sanjana and Zade, Amrutraj and Nikam, Chaitali and Gomare, Mangala and Chatterjee, Anirvan},
  title = {Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases},
  journal = {Microbiology Spectrum},
  year = {2024},
  volume = {12},
  number = {5},
  doi = {10.1128/spectrum.02770-23}
}
Kostenlos starten →